These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients. Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177 [TBL] [Abstract][Full Text] [Related]
6. Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. Coen G; De Paolis P; Ballanti P; Pierantozzi A; Pisanò S; Sardella D; Mantella D; Pellegrino L; Silvestrini G; Iappelli M; Di Giulio S J Nephrol; 2011; 24(3):313-21. PubMed ID: 20954136 [TBL] [Abstract][Full Text] [Related]
7. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804 [TBL] [Abstract][Full Text] [Related]
8. Coronary artery calcifications in children with end-stage renal disease. Civilibal M; Caliskan S; Adaletli I; Oflaz H; Sever L; Candan C; Canpolat N; Kasapcopur O; Kuruoglu S; Arisoy N Pediatr Nephrol; 2006 Oct; 21(10):1426-33. PubMed ID: 16821026 [TBL] [Abstract][Full Text] [Related]
9. The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients . Ganidagli B; Nacar H; Yildiz YS; Dagli H; Erken E; Altunoren O; Gungor O Clin Nephrol; 2019 Jan; 91(1):9-16. PubMed ID: 30369401 [TBL] [Abstract][Full Text] [Related]
10. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis. El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103 [TBL] [Abstract][Full Text] [Related]
11. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. Ozkok A; Kekik C; Karahan GE; Sakaci T; Ozel A; Unsal A; Yildiz A BMC Nephrol; 2013 Nov; 14():241. PubMed ID: 24180481 [TBL] [Abstract][Full Text] [Related]
12. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. Goodman WG; Goldin J; Kuizon BD; Yoon C; Gales B; Sider D; Wang Y; Chung J; Emerick A; Greaser L; Elashoff RM; Salusky IB N Engl J Med; 2000 May; 342(20):1478-83. PubMed ID: 10816185 [TBL] [Abstract][Full Text] [Related]
13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
14. Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function. Park KS; Chang JW; Kim TY; Kim HW; Lee EK; Kim HS; Yang WS; Kim SB; Park SK; Lee SK; Park JS Am J Clin Nutr; 2011 Dec; 94(6):1465-70. PubMed ID: 22030227 [TBL] [Abstract][Full Text] [Related]
15. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345 [TBL] [Abstract][Full Text] [Related]
16. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism. Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267 [TBL] [Abstract][Full Text] [Related]
17. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients. Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272 [TBL] [Abstract][Full Text] [Related]
18. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Balci M; Kirkpantur A; Gulbay M; Gurbuz OA Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275 [TBL] [Abstract][Full Text] [Related]
19. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification. Fu X; Cui QQ; Ning JP; Fu SS; Liao XH Med Sci Monit; 2015 Nov; 21():3467-73. PubMed ID: 26558428 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Qunibi WY; Nolan CA; Ayus JC Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]